‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight
New triple agonist drug produces substantial weight loss in diabetic patients.
← Back to stories
National2 articles from 2 sources across the spectrum· Updated 7d ago
2 across the spectrum · tap a section to jump
How each side is putting it
Left
0 viewpointsNo Left coverage yet.
A blind spot on this side of the story.
Center
1 viewpointNew triple agonist drug produces substantial weight loss in diabetic patients
Right
1 viewpoint‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight